65,437 trials
Chronic Hepatitis C
Primary: Percentage of Participants Achieving Sustained Virological Response 12 Weeks Post-treatment (SVR12) — 94.5 percentage of participants
Renal Cell Carcinoma
Primary: Percent Change From Baseline in Activated and Memory T Cells — NA; NA; NA; NA Percentage
Upper Airway Obstruction · Respiratory Insufficiency · Respiratory Failure
Primary: Oxygen Desaturation Index 4% (ODI4%) — 3.16; 7.61 events per hour — p=0.0134
Neoplasms
Primary: Percentage of Participants With Dose Limiting Toxicities (DLT) in Cycle 1 for the Determination of the Maximum Tolerated Dose (MTD) of Volasertib — 0.0; 0.0; 16.7; 23.5…
Schizophrenia
Primary: Change From Baseline to Week 48 in the PANSS Total Score — 66.5; -5.0 Units on a scale
Breast Cancer
Primary: Size Error in Millimeters — 0 milimeters
Oncology
Primary: Pharmacokinetic (PK) Parameter: AUCtau of ENTO — 1788.9; 7490.0; 4081.5; 3318.0 h*ng/mL
Burns · Smoke Inhalation Injury
Primary: Number of Families With a Fire Escape Plan (Ascertained From Self-completion Questionnaire). — 120; 108; 119 Participants
Schizophrenia · Schizophrenia-related Psychotic Disorder
Primary: Change From Baseline To End Of Treatment (Day 43) In Positive And Negative Syndrome Scale (PANSS) Total Score — 79.3; 80.6; 68.1; 71.9 score on a scale — p=0.1332
Sexual Aggression · Heavy Drinking
Primary: Sexual Aggression Intentions — 1.58; 1.90; 2.18; 1.53 score on a scale — p=.041
Tuberculosis
Primary: Rate of Change in Time to Sputum Culture Positivity (TTP) Over 8 Weeks in the Mycobacterial Growth Indicator Tube (MGIT) System — 4.878; 5.182; 4.046; 5.194 percentage…
Breast Cancer
Primary: Progression-free Survival in Patients With a High vs. Low Cumulative Methylation Index (CMI) Value — 2.1; 5.8 months — p=.0002
Stroke · Ischemic Stroke
Primary: Depression — .7; .79 units on a scale
Neutropenia
Primary: Area Under the Plasma Concentration Versus Time Curve (AUC) From Time 0 to 24 Hours Post-dose for POS — 17800; 27300; 25600; 29800 hr*ng/mL
Lupus Erythematosus, Cutaneous
Primary: Number of Participants With Emergent Chemistry Results by Potential Clinical Importance (PCI) Criteria — 0; 11; 0; 10 Participants